Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma

Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma

US Patent 11234955 · Granted Feb 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of an RSK inhibitor2025
Therapeutic benefit of suboptimally administered chemical compounds2025
Compositions and methods to improve the therapeutic benefit of suboptimally admi2025
Methods for sub-austenite transformation temperature deposition of inorganic par2024
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas2023
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas2023
Compositions and methods for detecting and/or treating inflammation2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination wit2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination wit2023
Therapeutic benefit of suboptimally administered chemical compounds2022
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pe2022
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pe2022